PRESS RELEASE: Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference Link: https://lnkd.in/egub68mC
Akebia Therapeutics’ Post
More Relevant Posts
-
4/17 Webinar: How to take back control of your #ITHelpdesk from #Slack DMs. Cohere, Xilio Therapeutics, Foqal share experience. Register here: https://hubs.ly/Q02pyRpN0
-
The hereditary angioedema therapeutics market size is expected to see rapid growth in the next few years. It will grow to $13.47 billion in 2028 at a compound annual growth rate (CAGR) of 18.8%. https://lnkd.in/gwmKbFZY #marketresearch #marketintelligence #marketreport #industryanalysis #TheBusinessResearchCompany #TBRC #GlobalMarketModel
-
-
Founder, CEO at PTM Therapeutics | Fractional Life Sciences Counsel | Former VP & General Counsel
Check this out! As a scientist, patent attorney and entrepreneur, I believe that innovation is the genesis of therapeutics that changes patients lives. Get informed and support strong patent rights to protect these innovations and the businesses that they help build!
very proud to announce that Dr. Jennifer Cheng, founder and CEO of PTM Therapeutics, has a published an op-ed article in The Mercury News concerning the TRIPS Waiver extension. you can read it here: https://lnkd.in/gtjGi-NJ
-
Join our webinar with Cuong Do, founder and Chairman of M6P Therapeutics, to hear how their breakthrough technology is driving the development of the next generation of enzyme replacement therapies for a wide range of conditions. July 23 at 11 AM ET https://hubs.la/Q02GY-6z0
-
-
Discover how VLE Therapeutics sets the gold standard in lentiviral vector (LV) production. Our streamlined methods pave the way for next-generation therapeutics, delivering superior quality and efficiency. Learn more 👉 https://ow.ly/a5IJ50SeEr7
-
-
Editor/Founder The Pharmaceutical Marketing Group - Executive Director at Clinician Burnout Foundation
While we have witnessed digital capabilities navigating the pharma through evolving landscape, the question in the realm of CGT remains - how much closer are we to demonstrating value using the universal language of data? Join senior leader from Sumitomo Pharma America, Microvascular Therapeutics, Mustang Bio and Bayer next month, to explore their visions on key trends shaping the future of CGT clinical development: https://bit.ly/3OkH4Ly
-
-
Discover how VLE Therapeutics sets the gold standard in lentiviral vector (LV) production. Our streamlined methods pave the way for next-generation therapeutics, delivering superior quality and efficiency. Learn more 👉 https://ow.ly/a5IJ50SeEr7
-
-
Join our webinar with Cuong Do, founder and Chairman of M6P Therapeutics, to hear how their breakthrough technology is driving the development of the next generation of enzyme replacement therapies for a wide range of conditions. July 23 at 11 AM ET https://hubs.la/Q02GYRkw0
-
-
Join our webinar with Cuong Do, founder and Chairman of M6P Therapeutics, to hear how their breakthrough technology is driving the development of the next generation of enzyme replacement therapies for a wide range of conditions. July 23 at 11 AM ET https://hubs.la/Q02GYPpY0
-
-
Curious about how to gain a competitive advantage in CRISPR therapeutics? Check out our latest blog on the advantages of simplified licensing for CRISPR technologies --> https://lnkd.in/gbcs-5y5
Suffolk Transportation Services
3mo.99 cents come on really Butler. What do you care about shareholders. Meanwhile you are getting millions and not doing anything positive Totally freaking incompetent lack of leadership.